AccessGUDID - DEVICE: LifeSign QuikScreen 11 (00863480002106)

GUDID

Device Identifier (DI) Information

Brand Name: LifeSign QuikScreen 11
Version or Model: 60B02
Commercial Distribution Status: Not in Commercial Distribution
Catalog Number:
Company Name: Lifesign L.L.C.

Primary DI Number: 00863480002106
Issuing Agency: GS1
Commercial Distribution End Date: September 25, 2016
Device Count: 1
Labeler D-U-N-S® Number*: 010964864 *Terms of Use

Device Description: LifeSign QuikScreen 11: Amphetamine (AMP) 1000 ng/ml Phencyclidine (PCP) 25 ng/ml Methamphetamine (MET) 1000 ng/ml Opiate (OPI) 2000 ng/ml Barbiturates (BAR) 300 ng/ml Benzodiazepine (BZD) 300 ng/ml Marijuana (THC) 50 ng/ml Methadone (MAD) 300 ng/ml Oxycodone (OXY) 100 ng/ml Tricyclic Antidepressants (TCA) 1000 ng/ml Cocaine (COC) 300ng/ml

Device Characteristics

What MRI safety information does the labeling contain?	Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437):	No
Device labeled as "Not made with natural rubber latex":	No
For Single-Use:	Yes
Prescription Use (Rx):	No
Over the Counter (OTC):	No
Kit:	No
Combination Product:	No
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P):	No

GMDN

[?]

GMDN Term Code	GMDN Term Name	GMDN Term Definition	GMDN Term Status [?]	Implantable?
55463	Drug/toxicology screen adulteration IVD, kit, rapid spectrophotometry, clinical	A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of drug and/or toxicology screen adulteration of a clinical specimen within a short period, relative to standard laboratory testing procedures, using a rapid spectrophotometry method. This is a rapid test commonly used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.	Active	false

FDA Product Code

[?]

Product Code	Product Code Name
DJG	Enzyme Immunoassay, Opiates
LFH	U.V. Spectrometry, Tricyclic Antidepressant Drugs
DJR	Enzyme Immunoassay, Methadone
DJC	Thin Layer Chromatography, Methamphetamine
LDJ	Enzyme Immunoassay, Cannabinoids
DIO	Enzyme Immunoassay, Cocaine And Cocaine Metabolites
JXM	Enzyme Immunoassay, Benzodiazepine
DIS	Enzyme Immunoassay, Barbiturate
DKZ	Enzyme Immunoassay, Amphetamine

FDA Premarket Submission

FDA Premarket Submission Number [?]	Supplement Number [?]
K071489	000

Device Exempt from Premarket Submission: No CLOSE

Sterilization

Device Packaged as Sterile: No
Requires Sterilization Prior to Use: No

Sterilization Method [?]
No Sterilization Methods Found

Storage and Handling

[?]

Storage and Handling
No storage/handling found

Clinically Relevant Size

[?]

Size Type Text
No Device Sizes

Device Record Status

Public Device Record Key: 8300f52e-0d02-4ace-9b70-b0771deec64e
Public Version Date: July 06, 2023
Public Version Number: 6
DI Record Publish Date: September 24, 2016

Alternative and Additional Identifiers Additional Identifiers

Package DI

[?]

Package DI Number	Quantity per Package	Contains DI Package	Package Discontinue Date	Package Status	Package Type
20863480002100	4	10863480002103	2013-02-01	Not in Commercial Distribution	Shipper Box
10863480002103	25	00863480002106	2013-02-01	Not in Commercial Distribution	Kit Box